Irbesartan vs Metformin
Irbesartan vs Metformin: Overview
This comparison examines the pharmacological differences between Irbesartan and Metformin.
Mechanism of Action
Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.
Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.
Pharmacokinetics
Half-life: Irbesartan β 11-15 hours; Metformin β 4-9 hours.
Chemical Properties
Molecular Formula: Irbesartan β C25H28N6O; Metformin β C4H11N5.
Molecular Weight: Irbesartan β 428.5320 g/mol; Metformin β 129.1640 g/mol.
Type: Irbesartan β Small molecule; Metformin β Small molecule.